A case of Graves' disease with false hyperthyrotropinemia who developed silent thyroiditis.

M Iitaka, J Ishii, N Ishikawa, H Yoshimura, N Momotani, H Saitou, K Ito
{"title":"A case of Graves' disease with false hyperthyrotropinemia who developed silent thyroiditis.","authors":"M Iitaka,&nbsp;J Ishii,&nbsp;N Ishikawa,&nbsp;H Yoshimura,&nbsp;N Momotani,&nbsp;H Saitou,&nbsp;K Ito","doi":"10.1507/endocrj1954.38.667","DOIUrl":null,"url":null,"abstract":"<p><p>We encountered a patient who developed silent thyroiditis during the course of Graves' disease. The diagnosis of silent thyroiditis was made on the basis of a low thyroidal 131I uptake, no response to the thyrotropin releasing hormone (TRH) test, and subsequent hypothyroidism despite the presence of high titers of thyrotropin (TSH) receptor antibody (TRAb) and thyroid stimulating antibody (TSAb). The patient, in addition, had a discrepancy between serum TSH and thyroid hormone values. This was due to the presence of interfering substances that react to mouse IgG in the sera since serum TSH levels were decreased in a dose dependent manner by the addition of increasing amounts of mouse IgG to the sera. It should therefore be noted that silent thyroiditis can develop in patients with Graves' disease. Furthermore, clinicians should be aware that two-site immunoassay kits that use mouse monoclonal antibodies are subject to interference by some substances, possibly antibodies which react to mouse IgG.</p>","PeriodicalId":11534,"journal":{"name":"Endocrinologia japonica","volume":"38 6","pages":"667-71"},"PeriodicalIF":0.0000,"publicationDate":"1991-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1507/endocrj1954.38.667","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinologia japonica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1507/endocrj1954.38.667","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

We encountered a patient who developed silent thyroiditis during the course of Graves' disease. The diagnosis of silent thyroiditis was made on the basis of a low thyroidal 131I uptake, no response to the thyrotropin releasing hormone (TRH) test, and subsequent hypothyroidism despite the presence of high titers of thyrotropin (TSH) receptor antibody (TRAb) and thyroid stimulating antibody (TSAb). The patient, in addition, had a discrepancy between serum TSH and thyroid hormone values. This was due to the presence of interfering substances that react to mouse IgG in the sera since serum TSH levels were decreased in a dose dependent manner by the addition of increasing amounts of mouse IgG to the sera. It should therefore be noted that silent thyroiditis can develop in patients with Graves' disease. Furthermore, clinicians should be aware that two-site immunoassay kits that use mouse monoclonal antibodies are subject to interference by some substances, possibly antibodies which react to mouse IgG.

Graves病合并假甲状腺球蛋白高血症并发隐匿性甲状腺炎1例。
我们遇到一位在格雷夫斯病病程中发展为隐匿性甲状腺炎的病人。无症状甲状腺炎的诊断是基于低甲状腺131I摄取,对促甲状腺激素释放激素(TRH)试验无反应,尽管存在高滴度的促甲状腺激素(TSH)受体抗体(TRAb)和促甲状腺抗体(TSAb),但随后的甲状腺功能减退。此外,患者血清TSH和甲状腺激素值存在差异。这是由于在血清中加入越来越多的小鼠IgG,血清TSH水平以剂量依赖的方式降低,因此存在与血清中小鼠IgG发生反应的干扰物质。因此,应注意,隐匿性甲状腺炎可发生在格雷夫斯病患者。此外,临床医生应该意识到,使用小鼠单克隆抗体的双位点免疫测定试剂盒会受到某些物质的干扰,可能是对小鼠IgG起反应的抗体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信